Over the past 3 years, nanotechnology has begun to take the shape of big business, with numerous companies spun off from academia, and worldwide government and private investment estimated at over $4 billion. Theta’s report is designed to inform corporate strategic planners and marketing executives of the commercial status and future of nanotechnology-related medical devices, diagnostics andtherapeutics, and the consequences that nanotechnology will have in the healthcare industry. This study will give you comprehensive, practical information required to develop solutions and strategies to succeed in this rapidly developing market.
An essential strategic resource, Theta’s Nanotechnology: Emerging Healthcare Applications & Markets includes reviews and analyses of the following topics:
Types of medical devices, diagnostics and therapeutics under development
Uses of the nanotech-based products that are currently on the market
Information on the companies that are developing and marketing these products
Information on the major academic research groups developing potential products, and which might represent opportunities for technology transfer to industry
The report's highlights include:
Status of medical nanotech- related clinical trials
Target launch date of nanotech products
Disease states targeted and their prevalence
Technical issues facing developers
Market challenges
Market estimates and predictions for the years 2003-2007
(0 items)
